huberman retatrutide Andrew Huberman, Ph.D. (@hubermanlab) • Instagram photos and videos Huberman Lab - Listen here

Research suggests: Synergistic effects on weight loss exceeding predictions from single or dual receptor activation Complementary regulation of both energy intake (primarily GLP-1 and GIP) and energy expenditure (primarily glucagon) Balanced effects on glucose metabolism through multiple mechanisms Potential cardiovascular benefits through lipid metabolism improvements and blood pressure reduction [CALLOUT BOX Highlighted] Mechanistic Insight: GLP3 s triagonist approach represents an evolution beyond dual GLP-1/GIP agonism, with the addition of glucagon receptor activation appearing to enhance weight loss efficacy and metabolic benefits

To help manage GLP-1 supply, Optum Rx provides clients with additional utilization management strategies to prevent stockpiling of GLP-1 agonists

Studies show people on weight loss medications often reduce their calorie intake by 1639%, which can also mean fewer essential nutrients

The mechanism also explains why medical oversight matters

We analyzed the weekly incidence of side effects during the first two weeks that a participant recorded a given dose amount, using a Bayesian logistic mixed-effects model